Related Experiment Video
Updated: Jun 14, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1
Shikha Khatri1, Hasmik Yepiskoposyan, Catherine A Gallo
1Department of Cancer and Cell Biology, University of Cincinnati, Cincinnati, Ohio 45267, USA.
Abstract:
Akt signal transduction induces coordinated increases in glycolysis and apoptosis resistance in a broad spectrum of cancers. Downstream of Akt, the FoxO transcription factors regulate apoptosis via Bim, but the contributions of FoxOs in regulating Akt-induced glycolysis are not well described. We find that FoxO3a knockdown is sufficient to induce apoptosis resistance in conjunction with elevated glycolysis. Glycolysis in FoxO3a-deficient cells was associated with increased S6K1 phosphorylation and was sensitive to rapamycin, an inhibitor of the mTORC1 pathway that has been linked to glycolysis regulation. We show that mTORC1-dependent glycolysis is increased in FoxO3a knockdown cells due to decreased expression of the TSC1 tumor suppressor that opposes mTORC1 activation. FoxO3a binds to and transactivates the TSC1 promoter, indicating a key role for FoxO3a in regulating TSC1 expression. Together, these data demonstrate that FoxO3a regulates glycolysis downstream of Akt through transcriptional control of Tsc1.
Insights
The transcription factor FoxO3a regulates cancer cell glycolysis by controlling Tsc1 expression. Loss of FoxO3a increases glycolysis and apoptosis resistance, highlighting a new therapeutic target in cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Akt signaling promotes cancer cell survival and proliferation by increasing glycolysis and resistance to apoptosis.
- FoxO transcription factors are key regulators of apoptosis downstream of Akt, but their role in glycolysis is unclear.
Purpose of the Study:
- To investigate the role of FoxO transcription factors, specifically FoxO3a, in regulating Akt-induced glycolysis in cancer cells.
- To elucidate the molecular mechanisms by which FoxO3a influences glycolysis and apoptosis resistance.
Main Methods:
- FoxO3a knockdown in cancer cells.
- Measurement of glycolysis rates and apoptosis.
- Analysis of signaling pathways including mTORC1, S6K1, and TSC1.
- Luciferase reporter assays to assess transcriptional activity on the TSC1 promoter.
Main Results:
- FoxO3a knockdown led to increased glycolysis and apoptosis resistance.
- Elevated glycolysis in FoxO3a-deficient cells was linked to mTORC1 activation and decreased TSC1 expression.
- FoxO3a was found to directly bind and transactivate the TSC1 promoter, indicating transcriptional regulation.
- Rapamycin treatment, an mTORC1 inhibitor, reduced glycolysis in FoxO3a-deficient cells.
Conclusions:
- FoxO3a plays a critical role in regulating cancer cell glycolysis downstream of Akt signaling.
- FoxO3a controls glycolysis by transcriptionally upregulating TSC1, which in turn inhibits mTORC1.
- Targeting FoxO3a or its downstream effectors may offer novel therapeutic strategies for cancers driven by Akt signaling.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
